🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
The primary purpose of this first-in-man study is to investigate whether a ...
Status
Completed
Location
Investigator Site
Start Date
2016-02-01
Trial ID
NCT02702648
This is a randomized, double-blind, placebo-parallel intervention clinical ...
Status
Unknown
Location
The Second Affiliated Hospital of Chongqing Medical University
Start Date
2022-05-01
Trial ID
NCT06127498
This study was originally designed as a Phase III randomized, double blind,...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2005-12-13
Trial ID
NCT00272987
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
This study serves, in part, to prepare for a future large cohort study. The...
Status
Recruiting
Location
University Hospital Antwerp
Start Date
2025-08-13
Trial ID
NCT06523374
Treatments Being Tested
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
This is a two-part, phase I/IIa study, intended to evaluate the safety, tol...
Status
Not Yet Recruiting
Location
Columbia University Medical Center
Start Date
2026-10
Trial ID
NCT07536282
The primary objective of this study is to identify a new radioligand for im...
Status
Withdrawn
Location
John Hopkins Hospital
Start Date
2020-01
Trial ID
NCT03939780
Treatments Being Tested
This study compares the efficacy of neoadjuvant low-dose radiotherapy plus ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01-20
Trial ID
NCT06804850
Treatments Being Tested